Geographic atrophy is an eye condition that can severely impact a person’s vision, which can affect their routine and independence. Once a person develops geographic atrophy, it cannot be reversed and ...
TOKYO, Oct. 19, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the first results from the open-label extension trial of the Phase 3 ...
NORTHBROOK, Ill., March 26, 2024 /PRNewswire/ -- Iveric Bio, An Astellas Company (TSE: 4503, President and CEO: Naoki Okamura, "Astellas"), today announced the U.S. Centers for Medicare and Medicaid ...
Pooled post hoc analysis of GATHER1 and GATHER2 showed IZERVAY® (avacincaptad pegol intravitreal solution) reduced the risk of progressing to loss of driving eligibility compared with sham over 24 ...
Izervay is a brand-name medication that’s injected into the eye to treat a degenerative disease of the retina called geographic atrophy (GA). More common side effects of Izervay injections include ...
Izervay (avacincaptad pegol) is a brand-name eye injection prescribed for an advanced form of age-related macular degeneration. Izervay is not known to interact with other drugs. Izervay is prescribed ...
In GATHER2 open-label extension study, IZERVAY reduced GA growth 37-40.5% vs. projected sham, with earlier intervention resulting in greater protection of retinal tissue area Study results found no ...
Eye injections like the one for IZERVAY can cause an eye infection (endophthalmitis) or separation of layers of the retina (retinal detachment). Call your healthcare provider right away if you have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results